Cannabis Pharmaceuticals Global Market Report 2025

Global Cannabis Pharmaceuticals Market Report 2025

Cannabis Pharmaceuticals Global Market Report 2025 – By Product Type (Cannabinoid-Based Pharmaceuticals, Cannabis Extracts, Synthetic Cannabinoids), By Formulation Type (Capsules And Tablets, Oils And Tinctures, Topical Solutions), By Therapeutic Application (Cancer, Neurological Disorders, Pain Management), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), By End-User (Hospitals And Clinics, Rehabilitation Centers, Research Organizations) – Market Size, Trends, And Global Forecast 2025-2034

Name: Cannabis Pharmaceuticals Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Cannabis Pharmaceuticals Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Cannabis Pharmaceuticals Global Market Report 2025

Proud Members Of

Cannabis Pharmaceuticals Market Definition

Cannabis pharmaceuticals are prescription-grade medications made from cannabis-derived compounds, designed to address particular health conditions and produced under strict clinical and regulatory standards. These pharmaceuticals utilize the therapeutic benefits of cannabinoids, such as tetrahydrocannabinol (THC) and cannabidiol (CBD), to treat conditions including chronic pain, epilepsy, and multiple sclerosis.

The main indications in the cannabis pharmaceuticals include cannabinoid-based pharmaceuticals, Cannabis Extracts, and synthetic cannabinoids. Cannabinoid-based pharmaceuticals are drugs that incorporate synthetic or natural cannabinoids, such as THC and CBD, to address various health conditions. The various formulation types are capsules and tablets, oils and tinctures, and topical solutions used in therapeutic applications such as cancer, neurological disorders, and pain management. The various distribution channels include hospital pharmacies, online pharmacies, and retail pharmacies and are used by several end users, including hospitals and clinics, rehabilitation centers, and research organizations.

Cannabis Pharmaceuticals Market Segmentation

The cannabis pharmaceuticals market covered in this report is segmented –

1) By Product Type: Cannabinoid-Based Pharmaceuticals, Cannabis Extracts, Synthetic Cannabinoids

2) By Formulation Type: Capsules And Tablets, Oils And Tinctures, Topical Solutions

3) By Therapeutic Application: Cancer, Neurological Disorders, Pain Management

4) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

5) By End-User: Hospitals And Clinics, Rehabilitation Centers, Research Organizations

Subsegments:

1) By Cannabinoid-Based Pharmaceuticals: THC-Based Pharmaceuticals, CBD-Based Pharmaceuticals, Combination of THC and CBD Pharmaceuticals, Other Cannabinoid-Based Formulations

2) By Cannabis Extracts: Full-Spectrum Cannabis Extracts, Broad-Spectrum Cannabis Extracts, Isolate Cannabis Extracts (CBD Isolate)

3) By Synthetic Cannabinoids: Synthetic THC Analogues, Synthetic CBD Analogues, Synthetic Cannabinoid Receptor Agonists, Designer Synthetic Cannabinoids

Cannabis Pharmaceuticals Market Size and growth rate 2025 to 2029: Graph

Cannabis Pharmaceuticals Market Size 2025 And Growth Rate

The cannabis pharmaceuticals market size has grown exponentially in recent years. It will grow from $6.03 billion in 2024 to $9.45 billion in 2025 at a compound annual growth rate (CAGR) of 56.66%. The growth in the historic period can be attributed to increase in legalization of medical cannabis, rise in awareness of cannabinoid therapeutic benefits, growth in prevalence of chronic and neurological disorders, supportive regulatory frameworks, expanding pharmaceutical investments, and shift in public perception toward cannabis use in healthcare.

Cannabis Pharmaceuticals Market Growth Forecast

The cannabis pharmaceuticals market size is expected to see exponential growth in the next few years. It will grow to $56.37 billion in 2029 at a compound annual growth rate (CAGR) of 56.29%. The growth in the forecast period can be attributed to increasing regulatory approvals, growing awareness of medical cannabis benefits, expanding applications in pain and neurological disorder management, rising prevalence of chronic illnesses, innovations in drug delivery systems, and the establishment of favorable reimbursement policies. Major trends in the forecast period include advancements in cannabinoid extraction technologies, development of targeted drug delivery systems, adoption of synthetic cannabinoid formulations, improved clinical trial methodologies, and integration of artificial intelligence for drug discovery.

Book your 30 minutes free consultation with our research experts

Cannabis Pharmaceuticals Market Driver: Increasing Epilepsy Cases Boost Demand For Cannabis-Based Treatments

The rise in incidence of epilepsy is expected to drive the cannabis pharmaceuticals market going forward. Epilepsy refers to a neurological disorder characterized by recurrent, unprovoked seizures caused by abnormal electrical activity in the brain. The rise in epilepsy cases can be attributed to better diagnosis, increased awareness, and enhanced reporting, alongside potential environmental, genetic, and lifestyle influences. Cannabis pharmaceuticals have shown potential in helping manage epilepsy by utilizing cannabinoids like CBD to reduce the frequency and severity of seizures in patients who do not respond well to traditional anti-epileptic drugs. For instance, in April 2022, according to the European Brain Council, a Belgium-based non-profit organization, over 600 neurological diseases and nearly 300 psychiatric conditions afflict millions globally, including 65 million with epilepsy. Moreover, in July 2024, according to the Alzheimer Society of Canada, a Canada-based health charity, according to estimates, 771,939 Canadians are expected to have dementia on January 1, 2025, and by 2030, that number is predicted to rise to nearly one million. Therefore, the rise in incidence of epilepsy is driving the growth of the cannabis pharmaceuticals market.

Global Cannabis Pharmaceuticals Market Major Players

Major companies operating in the cannabis pharmaceuticals market are Curaleaf Holdings Inc., Aphria Inc., Green Thumb Industries Inc., Trulieve Cannabis Corp., Tilray Inc., Cresco Labs Inc., Columbia Care Inc., Acreage Holdings Inc., Canopy Growth Corporation, Aurora Cannabis Inc., MedMen Enterprises Inc., OrganiGram Holdings Inc., Cronos Group, Enveric Biosciences Inc., Auxly Cannabis Group Inc., Valens Company Inc., Charlotte's Web Holdings Inc., Medical Marijuana Inc., Aleafia Health Inc., Supreme Cannabis Company Inc., Avicanna Inc., Emerald Health Therapeutics Inc.

Global Cannabis Pharmaceuticals Market Trend: Advancing Medical Cannabis Production To Meet Global Demand

Major companies operating in the cannabis pharmaceuticals market are focusing on developing innovative products such as advanced medical cannabis formulations to address a range of medical conditions and improve patient outcomes. Advanced medical cannabis formulations refer to specially designed cannabis-based products that are optimized for therapeutic use, incorporating precise doses of cannabinoids like THC and CBD. For instance, in April 2024, Canexis Pharma AG, a Switzerland-based pharmaceutical company, received manufacturing and narcotics licenses from Swissmedic for cannabis pharmaceuticals. These approvals empower the company to produce premium-grade medicinal active ingredients derived from CBD and THC. This development positions Canexis to meet the growing demand for medical cannabis both within Switzerland and globally. By obtaining these licenses, the company demonstrates its compliance with stringent regulatory standards, enhancing its credibility and ability to contribute to the rapidly evolving medical cannabis market.

Cannabis Pharmaceuticals Market Merger And Acquisition: Strategic Acquisition Expands Flora Growth's Global Capabilities

In December 2022, Flora Growth Corp., a US-based cannabis products manufacturing company, acquired Franchise Global Health Inc. for an amount of $19.5 million. The acquisition strengthens Flora's global reach, expanding its EU distribution network and client base, with a key focus on Germany's growing cannabis market. Additionally, it enhances Flora's capacity to meet rising medical and pharmaceutical cannabis demand. Franchise Global Health Inc. is a Canada-based pharmaceutical company primarily engaged in the medical cannabis and pharmaceutical industries.

Regional Outlook For The Global Cannabis Pharmaceuticals Market

North America was the largest region in the cannabis pharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cannabis pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cannabis pharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cannabis Pharmaceuticals Market?

The cannabis pharmaceuticals market consists of sales of dronabinol (synthetic THC) and cannabidiol (CBD) oil used to treat various medical conditions. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Cannabis Pharmaceuticals Industry?

The cannabis pharmaceuticals market research report is one of a series of new reports from The Business Research Company that provides cannabis pharmaceuticals market statistics, including the cannabis pharmaceuticals industry's global market size, regional shares, competitors with a cannabis pharmaceuticals market share, detailed cannabis pharmaceuticals market segments, market trends and opportunities, and any further data you may need to thrive in the cannabis pharmaceuticals industry. This cannabis pharmaceuticals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Cannabis Pharmaceuticals Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	9.45 billion
Revenue Forecast In 2034	$56.37 billion
Growth Rate	CAGR of 56.29% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The cannabis pharmaceuticals market covered in this report is segmented – 1) By Product Type: Cannabinoid-Based Pharmaceuticals, Cannabis Extracts, Synthetic Cannabinoids 2) By Formulation Type: Capsules And Tablets, Oils And Tinctures, Topical Solutions 3) By Therapeutic Application: Cancer, Neurological Disorders, Pain Management 4) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies 5) By End-User: Hospitals And Clinics, Rehabilitation Centers, Research Organizations Subsegments: 1) By Cannabinoid-Based Pharmaceuticals: THC-Based Pharmaceuticals, CBD-Based Pharmaceuticals, Combination of THC and CBD Pharmaceuticals, Other Cannabinoid-Based Formulations 2) By Cannabis Extracts: Full-Spectrum Cannabis Extracts, Broad-Spectrum Cannabis Extracts, Isolate Cannabis Extracts (CBD Isolate) 3) By Synthetic Cannabinoids: Synthetic THC Analogues, Synthetic CBD Analogues, Synthetic Cannabinoid Receptor Agonists, Designer Synthetic Cannabinoids
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Curaleaf Holdings Inc., Aphria Inc., Green Thumb Industries Inc., Trulieve Cannabis Corp., Tilray Inc., Cresco Labs Inc., Columbia Care Inc., Acreage Holdings Inc., Canopy Growth Corporation, Aurora Cannabis Inc., MedMen Enterprises Inc., OrganiGram Holdings Inc., Cronos Group, Enveric Biosciences Inc., Auxly Cannabis Group Inc., Valens Company Inc., Charlotte's Web Holdings Inc., Medical Marijuana Inc., Aleafia Health Inc., Supreme Cannabis Company Inc., Avicanna Inc., Emerald Health Therapeutics Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Cannabis Pharmaceuticals Market Characteristics

3. Cannabis Pharmaceuticals Market Trends And Strategies

4. Cannabis Pharmaceuticals Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Cannabis Pharmaceuticals Growth Analysis And Strategic Analysis Framework

5.1. Global Cannabis Pharmaceuticals PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Cannabis Pharmaceuticals Market Growth Rate Analysis

5.4. Global Cannabis Pharmaceuticals Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Cannabis Pharmaceuticals Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Cannabis Pharmaceuticals Total Addressable Market (TAM)

6. Cannabis Pharmaceuticals Market Segmentation

6.1. Global Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cannabinoid-Based Pharmaceuticals

Cannabis Extracts

Synthetic Cannabinoids

6.2. Global Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Capsules And Tablets

Oils And Tinctures

Topical Solutions

6.3. Global Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cancer

Neurological Disorders

Pain Management

6.4. Global Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

6.5. Global Cannabis Pharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals And Clinics

Rehabilitation Centers

Research Organizations

6.6. Global Cannabis Pharmaceuticals Market, Sub-Segmentation Of Cannabinoid-Based Pharmaceuticals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

THC-Based Pharmaceuticals

CBD-Based Pharmaceuticals

Combination of THC and CBD Pharmaceuticals

Other Cannabinoid-Based Formulations

6.7. Global Cannabis Pharmaceuticals Market, Sub-Segmentation Of Cannabis Extracts, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Full-Spectrum Cannabis Extracts

Broad-Spectrum Cannabis Extracts

Isolate Cannabis Extracts (CBD Isolate)

6.8. Global Cannabis Pharmaceuticals Market, Sub-Segmentation Of Synthetic Cannabinoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Synthetic THC Analogues

Synthetic CBD Analogues

Synthetic Cannabinoid Receptor Agonists

Designer Synthetic Cannabinoids

7. Cannabis Pharmaceuticals Market Regional And Country Analysis

7.1. Global Cannabis Pharmaceuticals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Cannabis Pharmaceuticals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cannabis Pharmaceuticals Market

8.1. Asia-Pacific Cannabis Pharmaceuticals Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cannabis Pharmaceuticals Market

9.1. China Cannabis Pharmaceuticals Market Overview

9.2. China Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cannabis Pharmaceuticals Market

10.1. India Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cannabis Pharmaceuticals Market

11.1. Japan Cannabis Pharmaceuticals Market Overview

11.2. Japan Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cannabis Pharmaceuticals Market

12.1. Australia Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cannabis Pharmaceuticals Market

13.1. Indonesia Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cannabis Pharmaceuticals Market

14.1. South Korea Cannabis Pharmaceuticals Market Overview

14.2. South Korea Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cannabis Pharmaceuticals Market

15.1. Western Europe Cannabis Pharmaceuticals Market Overview

15.2. Western Europe Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cannabis Pharmaceuticals Market

16.1. UK Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cannabis Pharmaceuticals Market

17.1. Germany Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cannabis Pharmaceuticals Market

18.1. France Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cannabis Pharmaceuticals Market

19.1. Italy Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cannabis Pharmaceuticals Market

20.1. Spain Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cannabis Pharmaceuticals Market

21.1. Eastern Europe Cannabis Pharmaceuticals Market Overview

21.2. Eastern Europe Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cannabis Pharmaceuticals Market

22.1. Russia Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cannabis Pharmaceuticals Market

23.1. North America Cannabis Pharmaceuticals Market Overview

23.2. North America Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cannabis Pharmaceuticals Market

24.1. USA Cannabis Pharmaceuticals Market Overview

24.2. USA Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cannabis Pharmaceuticals Market

25.1. Canada Cannabis Pharmaceuticals Market Overview

25.2. Canada Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cannabis Pharmaceuticals Market

26.1. South America Cannabis Pharmaceuticals Market Overview

26.2. South America Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cannabis Pharmaceuticals Market

27.1. Brazil Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cannabis Pharmaceuticals Market

28.1. Middle East Cannabis Pharmaceuticals Market Overview

28.2. Middle East Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cannabis Pharmaceuticals Market

29.1. Africa Cannabis Pharmaceuticals Market Overview

29.2. Africa Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cannabis Pharmaceuticals Market Competitive Landscape And Company Profiles

30.1. Cannabis Pharmaceuticals Market Competitive Landscape

30.2. Cannabis Pharmaceuticals Market Company Profiles

30.2.1. Curaleaf Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Aphria Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Green Thumb Industries Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Trulieve Cannabis Corp. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Tilray Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Cannabis Pharmaceuticals Market Other Major And Innovative Companies

31.1. Cresco Labs Inc.

31.2. Columbia Care Inc.

31.3. Acreage Holdings Inc.

31.4. Canopy Growth Corporation

31.5. Aurora Cannabis Inc.

31.6. MedMen Enterprises Inc.

31.7. OrganiGram Holdings Inc.

31.8. Cronos Group

31.9. Enveric Biosciences Inc.

31.10. Auxly Cannabis Group Inc.

31.11. Valens Company Inc.

31.12. Charlotte's Web Holdings Inc.

31.13. Medical Marijuana Inc.

31.14. Aleafia Health Inc.

31.15. Supreme Cannabis Company Inc.

32. Global Cannabis Pharmaceuticals Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cannabis Pharmaceuticals Market

34. Recent Developments In The Cannabis Pharmaceuticals Market

35. Cannabis Pharmaceuticals Market High Potential Countries, Segments and Strategies

35.1 Cannabis Pharmaceuticals Market In 2029 - Countries Offering Most New Opportunities

35.2 Cannabis Pharmaceuticals Market In 2029 - Segments Offering Most New Opportunities

35.3 Cannabis Pharmaceuticals Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Cannabis Pharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Cannabis Pharmaceuticals Market, Sub-Segmentation Of Cannabinoid-Based Pharmaceuticals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Cannabis Pharmaceuticals Market, Sub-Segmentation Of Cannabis Extracts, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Cannabis Pharmaceuticals Market, Sub-Segmentation Of Synthetic Cannabinoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Cannabis Pharmaceuticals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Cannabis Pharmaceuticals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Curaleaf Holdings Inc. Financial Performance

Table 80: Aphria Inc. Financial Performance

Table 81: Green Thumb Industries Inc. Financial Performance

Table 82: Trulieve Cannabis Corp. Financial Performance

Table 83: Tilray Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Cannabis Pharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Cannabis Pharmaceuticals Market, Sub-Segmentation Of Cannabinoid-Based Pharmaceuticals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Cannabis Pharmaceuticals Market, Sub-Segmentation Of Cannabis Extracts, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Cannabis Pharmaceuticals Market, Sub-Segmentation Of Synthetic Cannabinoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Cannabis Pharmaceuticals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Cannabis Pharmaceuticals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Cannabis Pharmaceuticals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Curaleaf Holdings Inc. Financial Performance

Figure 80: Aphria Inc. Financial Performance

Figure 81: Green Thumb Industries Inc. Financial Performance

Figure 82: Trulieve Cannabis Corp. Financial Performance

Figure 83: Tilray Inc. Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

How Will The Nuclear Medicine Market Grow In 2022?

What Is The Pediatric Imaging Market Overview In 2022?

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the rcm market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the medical tourism market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the clinical chemistry market market research report 2022 with industry size, share, segments and market growth

Cannabis Products Global Market Report 2025 – By Product Type (Flower, Concentrates, Other Product Types), By Usage (Medical, Recreational), By Compound (THC-Dominant, CBD-Dominant, Balanced THC & CBD), By Route Of Administration (Oral Solutions And Capsules, Smoking, Vaporizers, Topicals, Other Route Of Administrations) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cannabis Testing Global Market Report 2025 – By Test Type (Potency Testing, Pesticide Screening, Residual Solvent Screening, Heavy Metal Testing, Terpene Testing, Mycotoxin Testing, Other Test Types), By Technology (Chromatography, Spectroscopy, Other Technologies), By Portability (Standalone, Hand Held Devices), By End User (Testing Laboratories, Drug Manufacturers, Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cannabis Cultivation Global Market Report 2025 – By Type (Cannabis Indica, Cannabis Sativa), By Source (Flower or Buds, Leaves, Other Sources), By Application Outlook (Medical Consumption, Recreational Consumption, Industrial Consumption) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cannabis Extract Global Market Report 2025 – By Product Type (Oils, Tinctures), By Extract Type (Full Spectrum Extracts, Cannabis Isolates), By Sources (Hemp, Marijuana), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Application (Textile, Cosmetic, Pharmaceutical, Paper) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Recreational Cannabis Global Market Report 2025 – By Product (Oils, Transdermal Patches, Tablets, Capsule, Vape, Suppositories, Tinctures, Creams, Edibles, Other Products ), By Compound (Tetrahydrocannabinol (THC) Dominant, Cannabidiol (CBD) Dominant, Balanced Tetrahydrocannabinol (THC)), By Administration (Oral, Topical, Inhalation, Rectal, Sublingual), By Application (Chronic Pain, Cancer, Mental Disorder, Sleep Management, Other Applications), By End Users (Pharmaceuticals, Food, Beverages, Tobacco, Personal care, Research and Development Center) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cannabis Capsule Global Market Report 2025 – By Type (High Tetrahydrocannabinol Capsules, Tetrahydrocannabinol Or Cannabinol Balance Capsule, High Cannabinol Capsules), By Compound (Tetrahydrocannabinol (THC)-Dominant, Cannabidiol (CBD)-Dominant), By End User (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Sales) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Pharmaceutical API Manufacturing Global Market Report 2025 – By Therapy Area (Cardiovascular Disorders, Metabolic Disorders, Neurological Disorders, Oncology, Musculoskeletal Disorders, Other Therapeutics Uses), By API Type (Chemical API, Biological API), By Drug Type (Prescription Drugs, Over-The-Counter (OTC) Drugs) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Pharmaceutical Drugs And Biologics Logistics Market 2021 - By Type Of Service (Cold Chain Logistics, Non-Cold Chain Logistics), By Mode Of Transport (Air Transportation, Ocean Transportation, Land Transportation), By Pharmaceutical Type (Pharmaceutical Drugs, Biologics), By Therapeutic Area (Metabolic Disorders Drugs, Anti-Infective Drugs, Central Nervous System Drugs, Respiratory Diseases Drugs, Cardiovascular Drugs, Musculoskeletal Disorders Drugs, Oncology Drugs, Hematology Drugs, Monoclonal Antibodies (MAbS), Genito-Urinary Drugs, Gastrointestinal Drugs, Therapeutic Proteins, Dermatology Drugs, Vaccines, Ophthalmology Drugs), And By Region, Opportunities And Strategies - Global Forecast To 2030

View Report

Frequently Asked Questions

What is the definition of the Cannabis Pharmaceuticals market?

How will the Cannabis Pharmaceuticals market drivers and restraints affect the market dynamics? What forces will shape the Cannabis Pharmaceuticals industry going forward?

The Cannabis Pharmaceuticals market major growth driver - Increasing Epilepsy Cases Boost Demand For Cannabis-Based Treatments. For further insights on the Cannabis Pharmaceuticals market, request a sample here

What is the forecast market size or the forecast market value of the Cannabis Pharmaceuticals market?

The Cannabis Pharmaceuticals market size has grown strongly in recent years. The cannabis pharmaceuticals market size has grown exponentially in recent years. It will grow from $6.03 billion in 2024 to $9.45 billion in 2025 at a compound annual growth rate (CAGR) of 56.66%. The growth in the historic period can be attributed to increase in legalization of medical cannabis, rise in awareness of cannabinoid therapeutic benefits, growth in prevalence of chronic and neurological disorders, supportive regulatory frameworks, expanding pharmaceutical investments, and shift in public perception toward cannabis use in healthcare. The cannabis pharmaceuticals market size is expected to see exponential growth in the next few years. It will grow to $56.37 billion in 2029 at a compound annual growth rate (CAGR) of 56.29%. The growth in the forecast period can be attributed to increasing regulatory approvals, growing awareness of medical cannabis benefits, expanding applications in pain and neurological disorder management, rising prevalence of chronic illnesses, innovations in drug delivery systems, and the establishment of favorable reimbursement policies. Major trends in the forecast period include advancements in cannabinoid extraction technologies, development of targeted drug delivery systems, adoption of synthetic cannabinoid formulations, improved clinical trial methodologies, and integration of artificial intelligence for drug discovery. For further insights on the Cannabis Pharmaceuticals market, request a sample here

How is the Cannabis Pharmaceuticals market segmented?

The cannabis pharmaceuticals market covered in this report is segmented –
1) By Product Type: Cannabinoid-Based Pharmaceuticals, Cannabis Extracts, Synthetic Cannabinoids
2) By Formulation Type: Capsules And Tablets, Oils And Tinctures, Topical Solutions
3) By Therapeutic Application: Cancer, Neurological Disorders, Pain Management
4) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
5) By End-User: Hospitals And Clinics, Rehabilitation Centers, Research Organizations Subsegments:
1) By Cannabinoid-Based Pharmaceuticals: THC-Based Pharmaceuticals, CBD-Based Pharmaceuticals, Combination of THC and CBD Pharmaceuticals, Other Cannabinoid-Based Formulations
2) By Cannabis Extracts: Full-Spectrum Cannabis Extracts, Broad-Spectrum Cannabis Extracts, Isolate Cannabis Extracts (CBD Isolate)
3) By Synthetic Cannabinoids: Synthetic THC Analogues, Synthetic CBD Analogues, Synthetic Cannabinoid Receptor Agonists, Designer Synthetic Cannabinoids For further insights on the Cannabis Pharmaceuticals market, request a sample here

Which region has the largest share of the Cannabis Pharmaceuticals market? What are the other regions covered in the report?

Who are the major players in the Cannabis Pharmaceuticals market?

What are the key trends in the Cannabis Pharmaceuticals market?

Major trends in the Cannabis Pharmaceuticals market include Advancing Medical Cannabis Production To Meet Global Demand. For further insights on the Cannabis Pharmaceuticals market, request a sample here.

What are the major opportunities in the Cannabis Pharmaceuticals market? What are the strategies for the Cannabis Pharmaceuticals market?

For detailed insights on the major opportunities and strategies in the Cannabis Pharmaceuticals market, request a sample here.

How does the Cannabis Pharmaceuticals market relate to the overall economy and other similar markets?

For detailed insights on Cannabis Pharmaceuticals's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Cannabis Pharmaceuticals industry?

For detailed insights on the mergers and acquisitions in the Cannabis Pharmaceuticals industry, request a sample here.

What are the key dynamics influencing the Cannabis Pharmaceuticals market growth? SWOT analysis of the Cannabis Pharmaceuticals market.

For detailed insights on the key dynamics influencing the Cannabis Pharmaceuticals market growth and SWOT analysis of the Cannabis Pharmaceuticals industry, request a sample here.